BH3 Profiling Discriminates Response to Cytarabine-Based...

Molecular Cancer Therapeutics 2013 / 12 Vol. 12; Iss. 12

BH3 Profiling Discriminates Response to Cytarabine-Based Treatment of Acute Myelogenous Leukemia

Pierceall, W. E., Kornblau, S. M., Carlson, N. E., Huang, X., Blake, N., Lena, R., Elashoff, M., Konopleva, M., Cardone, M. H., Andreeff, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-13-0692
Date:
December, 2013
File:
PDF, 651 KB
english, 2013
Conversion to is in progress
Conversion to is failed